Medicine & Health

ShiNung Ching, an expert in neuroengineering, has been named chair of the Preston M. Green Department of Electrical & Systems Engineering at the McKelvey School of Engineering.

WashU Medicine researchers show that psychedelic compounds such as psilocybin appear to distort the link between blood flow and brain-cell functioning, which scientists use to track brain activity.

Researchers at WashU Medicine Mallinckrodt Institute of Radiology have received a $5 million grant from the National Institutes of Health (NIH) to study how patterns of brain aging and degeneration mirror early-life experiences.

Meaghan Creed, an associate professor of anesthesiology at WashU Medicine, has received a $3.3 million five-year grant from the National Institute on Drug Abuse to study dopamine system changes underlying depression symptoms in people with chronic neuropathic pain.

A group of researchers from Washington University in St. Louis has created a new kind of fiber-optic device to manipulate neural activity deep in the brain.

Christopher D. Smyser, MD, a renowned pediatric neurologist specializing in neonatal neurology and infant brain development, has been appointed director of the Division of Pediatric & Developmental Neurology in the Department of Neurology at WashU Medicine.

A new study by WashU researchers showed that family fights and peer bullying outweighed other risk factors for depression and other mental health problems, with adolescent girls suffering more than boys.

Using advanced biophysical and imaging techniques, Meredith Jackrel and her team at Washington University in St. Louis have isolated the protein Matrin-3 to better understand its role in neurodegenerative diseases.

Neuroscientists, clinicians and engineers at Washington University in St. Louis seek to develop personalized medicine strategies for refractory depression that would tailor drug dosage based on a patient’s age, genetics, health conditions, brain dynamics and neural circuits.

A multidisciplinary team of researchers at Washington University in St. Louis plans to investigate the neural mechanisms behind various controls of transcutaneous spinal cord stimulation in generating different leg movements with a five-year, nearly $3 million grant the National Institutes of Health (NIH).